RecruitingNot ApplicableNCT06894433

Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage

Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage: a Multicenter, Randomized, Controlled Clinical Trial

Sponsor

Southwest Hospital, China

Enrollment

280 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Intracerebral haemorrhage

Summary

This is a multicenter, randomized, controlled clinical trial comparing neuroendoscopic hematoma removal to craniotomy in the treatment of large intracerebral hemorrhage.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called craniotomy and a procedure called neuroendoscopic surgery for people with intracerebral haemorrhage. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.